The Canadian Glaucoma Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00262626|
Recruitment Status : Terminated
First Posted : December 7, 2005
Last Update Posted : December 7, 2005
Canadian National Institute for the Blind
Glaucoma Research Society of Canada
Merck Frosst Canada Ltd.
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Terminated|
|Primary Completion Date :||No date given|
|Study Completion Date :||June 1995|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Chauhan BC, Mikelberg FS, Artes PH, Balazsi AG, LeBlanc RP, Lesk MR, Nicolela MT, Trope GE; Canadian Glaucoma Study Group. Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change. Arch Ophthalmol. 2010 Oct;128(10):1249-55. doi: 10.1001/archophthalmol.2010.196. Epub 2010 Aug 9. Erratum in: Arch Ophthalmol. 2010 Dec;128(12):1633.
Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE; Canadian Glaucoma Study Group. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030. Erratum in: Arch Ophthalmol. 2008 Oct;126(10):1364.